Ritsuzo Kozuka

Osaka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Reply to "Did the COVID-19 pandemic disrupt the continuity of post-SVR surveillance in HCV-cured patients?"

Reply to "Did the COVID-19 pandemic disrupt the continuity of post-SVR surveillance in HCV-cured patients?"

Journal: Journal of gastroenterology

Published: August 17, 2026

12-Hydroxyheptadecatrienoic Acid Predicts Hepatocellular Carcinoma Development During Nucleos(t)ide Analogue Therapy.

12-Hydroxyheptadecatrienoic Acid Predicts Hepatocellular Carcinoma Development During Nucleos(t)ide Analogue Therapy.

Journal: Cancers

Published: January 01, 2026

Continuity of long-term follow-up in patients with chronic hepatitis C after sustained virologic response following direct-acting antiviral therapy: a nationwide real-world multicenter cohort study in Japan.

Continuity of long-term follow-up in patients with chronic hepatitis C after sustained virologic response following direct-acting antiviral therapy: a nationwide real-world multicenter cohort study in Japan.

Journal: Journal of gastroenterology

Published: November 09, 2025

Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational Cohort.

Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational Cohort.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: September 25, 2025

Long-Term Effectiveness of Tenofovir Alafenamide Versus Entecavir in Treatment-Naive Chronic Hepatitis B: A Real-World Evidence from the Global Alliance for the Study of Hepatitis B Virus.

Long-Term Effectiveness of Tenofovir Alafenamide Versus Entecavir in Treatment-Naive Chronic Hepatitis B: A Real-World Evidence from the Global Alliance for the Study of Hepatitis B Virus.

Journal: The American journal of gastroenterology

Published: July 11, 2025

Employment Status of Patients With Liver Disease: A Nationwide Questionnaire Survey in Japan.

Employment Status of Patients With Liver Disease: A Nationwide Questionnaire Survey in Japan.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: May 30, 2025

Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs.

Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs.

Journal: Journal of viral hepatitis

Published: May 01, 2025

Impact of metabolic dysfunction on treatment responses to nucleos(t)ide analogues in chronic hepatitis B: a retrospective multi-center REAL-B cohort study.

Impact of metabolic dysfunction on treatment responses to nucleos(t)ide analogues in chronic hepatitis B: a retrospective multi-center REAL-B cohort study.

Journal: EClinicalMedicine

Published: March 18, 2025

Differential HCC risk among HBV indeterminate types at baseline and by phase transition.

Differential HCC risk among HBV indeterminate types at baseline and by phase transition.

Journal: Gut

Published: February 07, 2025

Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B Study.

Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B Study.

Journal: Alimentary pharmacology & therapeutics

Published: February 05, 2025

Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues.

Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues.

Journal: Clinical and molecular hepatology

Published: November 27, 2024

Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation.

Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation.

Journal: Annals of hepatology

Published: September 03, 2024

Showing 1-12 of 61

Last Updated: 09/26/2026